Role of Ayurveda Poly herbal granules Punarnava Amritadi on Thalassemia Major disease
Phase 2
- Conditions
- Health Condition 1: D561- Beta thalassemia
- Registration Number
- CTRI/2019/08/020789
- Lead Sponsor
- Datta Meghe Institute of Medical Sciences Deemed to be University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed patients of Thalassemia major between the age of 4-15 years, on regular blood transfusion and iron chelating therapy, Irrespective of sex, caste, religion & socio-economic background.
Exclusion Criteria
Complicated cases like
HIV or HBV infection,
Hepatic failure,
Those requiring blood transfusion at an interval of 15 days or less.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the lakshanas of Pandu, To increase the period between Blood Transfusions &To reduce iron over load (Iron chelation).Timepoint: 2 months
- Secondary Outcome Measures
Name Time Method Biochemical, Hematological investigation.Timepoint: 2 months